[The influence of patient compliance with antiangiogenic therapy on its efficacy for neovascular age-related macular degeneration].


PURPOSE To study the level of patient compliance with Ranibizumab therapy and affecting factors. MATERIAL AND METHODS Medical records of 76 patients aged from 50 to 86 years (mean age 70.7 +/- 9.5 years) who underwent Ranibizumab treatment for neovascular age-related macular degeneration (AMD) during 2010-2014 were used. Demographic data, visual acuity… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics